{"product_id":"marimedinc-bcg-matrix","title":"MariMed Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eMariMed’s BCG Matrix snapshot highlights which product lines are scaling fast, which generate steady cash, and which may need reevaluation as market dynamics shift—essential reading for investors and strategists. Purchase the full BCG Matrix for a quadrant-by-quadrant breakdown, data-driven recommendations, and a ready-to-use strategic roadmap to optimize resource allocation and growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWholesale Brand Expansion in Illinois\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCash cow candidate: Illinois shows high growth with MariMed at 82% penetration of state dispensaries as of late 2025, making wholesale a revenue engine.\u003c\/p\u003e\n\u003cp\u003eAfter Mt. Vernon cultivation opened in Q3 2025, wholesale revenue rose 23% sequentially, driven by premium flower brands like Nature's Heritage capturing share.\u003c\/p\u003e\n\u003cp\u003eScaling requires heavy CAPEX for cultivation and processing; still, rapid share gains have eroded local competitors and improve margin leverage.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBetty's Eddies National Scaling\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs the top-selling edible brand in Massachusetts, Maryland, and Delaware, Betty's Eddies is MariMed’s primary growth engine and is being licensed into Maine and New York in 2025 to push national reach.\u003c\/p\u003e\n\u003cp\u003eRated a Star in the BCG matrix, the brand drives MariMed’s target of national brand ownership by 2030 and commands ~35% market share in core states.\u003c\/p\u003e\n\u003cp\u003eStrong demand for fruit chews means continued investment: MariMed plans $8–12M capex and $4M annual marketing spend through 2026 to scale production and maintain dominance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDelaware Adult-Use Market Leadership\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWith adult-use sales starting August 1, 2025, MariMed’s Delaware First State Compassion moved from steady medical to a Star, posting ~48% sequential retail revenue growth in Q3 2025 versus Q2 2025 and lifting site-level sales to about $3.2M monthly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVibations Cannabinoid Beverages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVibations Cannabinoid Beverages ranks among the top 10 cannabis beverage brands across multiple states and sits in the Stars quadrant of MariMed’s BCG Matrix due to high market share in a category projected to grow at ~18% CAGR through 2029 (Grand View Research).\u003c\/p\u003e\n\u003cp\u003eThe brand’s late-2025 entry into hemp-derived THC opens federally legal-adjacent channels, expanding addressable market beyond dispensaries and targeting mixed-retail and e-commerce distribution.\u003c\/p\u003e\n\u003cp\u003eThis expansion requires front-loaded distribution and compliance costs—estimated upfront spend of $2–4M per state for logistics, marketing, and testing—but could drive outsized share gains if national rollouts hit 20–30% penetration in key markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTop-10 brand status across multiple states\u003c\/li\u003e\n\u003cli\u003eCategory growth ≈18% CAGR to 2029\u003c\/li\u003e\n\u003cli\u003eHemp-THC launch late 2025 expands channels\u003c\/li\u003e\n\u003cli\u003eUpfront $2–4M per state distribution costs\u003c\/li\u003e\n\u003cli\u003ePotential 20–30% penetration in target markets\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMaryland Vertical Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMaryland Vertical Operations are positioned as a star: MariMed has expanded retail presence with the Thrive Wellness acquisition (2024) and serves nearly all state dispensaries, capturing higher margins via full vertical integration across cultivation, processing, and retail.\u003c\/p\u003e\n\u003cp\u003eThese assets require ongoing cash for build-outs and compliance but, given Maryland's adult-use growth—projected 20–25% CAGR 2025–27—they're on track to become MariMed's highest-value holdings.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eThrive Wellness added 2024; statewide retail reach ≈95%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh‑share winners: Betty’s Eddies, Vibations \u0026amp; IL scale—growth capex fueling hemp‑THC rollout\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: Strong high-share, high-growth assets—Betty's Eddies (~35% core-state share), Vibations (top-10; category ≈18% CAGR to 2029), IL wholesale (82% dispensary penetration), DE retail (+48% Q3 vs Q2 2025); planned capex $8–12M + $4M annual marketing; hemp-THC rollout $2–4M\/state.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2025 action\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBetty's Eddies\u003c\/td\u003e\n\u003ctd\u003e35% share\u003c\/td\u003e\n\u003ctd\u003eLicenses ME\/NY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVibations\u003c\/td\u003e\n\u003ctd\u003eTop-10; 18% CAGR\u003c\/td\u003e\n\u003ctd\u003eHemp-THC launch\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIllinois\u003c\/td\u003e\n\u003ctd\u003e82% pen.\u003c\/td\u003e\n\u003ctd\u003eWholesale scale\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix review of MariMed’s product lines with quadrant-specific strategies, investment recommendations, and trend-driven risks\/opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page MariMed BCG Matrix placing each business unit in a quadrant for quick strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMassachusetts Retail Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMariMed’s Massachusetts retail operations, led by Panacea Wellness, operate in a mature market with ~10 dispensaries and roughly $60–70M annual retail revenue in 2024, generating steady positive cash flow that funded ~40% of MariMed’s FY2024 expansion spend into new states. \u003c\/p\u003e\n\u003cp\u003eHigh brand recognition and a stable repeat-customer base keep promotional spend low—marketing intensity ~3–5% of sales versus 12–15% in new markets—making these stores a reliable liquidity source for growth. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNature's Heritage Core Market Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn Massachusetts and Maryland, Nature's Heritage—MariMed's premium flower brand—generates high margins and steady demand, delivering estimated annual wholesale revenue of ~$18–22M combined in 2024 with gross margins near 55%, per state sales reports.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManaged Services Agreements (MSAs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMariMed’s Managed Services Agreements (MSAs) deliver low-overhead revenue by managing third-party cannabis facilities without owning them; since 2017 MariMed reports this segment contributes about 12–15% of total revenue, avoiding capital expenditures and preserving cash.\u003c\/p\u003e\n\u003cp\u003eMSAs produce steady management fees and licensing income and in 2024 MariMed accelerated transitioning partners to its branded lines, lifting licensing income by ~18% year-over-year.\u003c\/p\u003e\n\u003cp\u003eCash from MSAs is routinely used to service corporate debt and fund R\u0026amp;D—MariMed allocated roughly $4.5M to product development and $2.2M to interest expense in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInHouse Value Brand Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eInHouse Value Brand Portfolio targets high-volume, price-sensitive customers with flower, vapes, and gummies that need low marketing spend due to clear value positioning; in 2025 MariMed reported these SKUs drove ~28% of wholesale unit volume across mature states.\u003c\/p\u003e\n\u003cp\u003eIn mature markets InHouse functions as a Cash Cow: it captures budget share, posts high inventory turnover (estimated 8–12 turns\/year), and funds corporate operations while Stars chase premium growth.\u003c\/p\u003e\n\u003cp\u003eIt provides a stable wholesale floor—about 15% of MariMed’s 2024 wholesale revenue—supporting margin stability and predictable cash flow for expansion of premium lines.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-volume, low-price SKUs: flower, vapes, gummies\u003c\/li\u003e\n\u003cli\u003eLow marketing spend; value positioning\u003c\/li\u003e\n\u003cli\u003eInventory turns: ~8–12\/year\u003c\/li\u003e\n\u003cli\u003eWholesale revenue floor: ~15% of 2024 wholesale sales\u003c\/li\u003e\n\u003cli\u003eDrives ~28% of unit volume in mature markets (2025)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHagerstown Cultivation and Processing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe Hagerstown, Maryland cultivation and processing facility is a mature, fully operational asset that completed major expansions in 2022–2023 to serve adult‑use markets and now runs near full capacity.\u003c\/p\u003e\n\u003cp\u003eWith primary capex complete, output exceeds 6,000 kg of flower-equivalent annually and cost per gram has fallen below $0.60, enabling strong gross margins and steady operating cash flow in 2024.\u003c\/p\u003e\n\u003cp\u003eThose cash flows covered roughly 25% of MariMed’s corporate overhead in FY 2024 and fund working capital and regional rollouts without new equity raises.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh volume: ~6,000 kg\/year\u003c\/li\u003e\n\u003cli\u003eLower cost: \u0026lt;$0.60\/gram\u003c\/li\u003e\n\u003cli\u003eFY24 support: ~25% corporate overhead\u003c\/li\u003e\n\u003cli\u003eCapex: completed 2022–2023\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMariMed’s Cash Engines: MA Retail, Hagerstown \u0026amp; InHouse Drive Stable Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMariMed’s Cash Cows: MA retail (Panacea) and MD cultivation (Hagerstown) plus InHouse brands and MSAs generated stable cash — ~ $60–70M MA retail, $18–22M Nature's Heritage wholesale, Hagerstown ~6,000 kg\/yr at \u0026lt;$0.60\/g, MSAs ~12–15% revenue; funded ~40% FY2024 expansion, covered ~25% corporate overhead, and drove ~28% unit volume in mature states (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003e2024\/25 KPI\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMA retail\u003c\/td\u003e\n\u003ctd\u003e$60–70M rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNature's Heritage\u003c\/td\u003e\n\u003ctd\u003e$18–22M rev, 55% GM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHagerstown\u003c\/td\u003e\n\u003ctd\u003e~6,000 kg, \u0026lt;$0.60\/g\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMSAs\u003c\/td\u003e\n\u003ctd\u003e12–15% total rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInHouse\u003c\/td\u003e\n\u003ctd\u003e~28% unit vol, 15% wholesale rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Transparency, Always\u003c\/span\u003e\u003cbr\u003eMariMed BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the exact MariMed BCG Matrix report you'll receive after purchase—no watermarks, no demo placeholders—just a fully formatted, analysis-ready document designed by strategy experts for immediate use in planning, presentations, or client delivery.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748008014201,"sku":"marimedinc-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/marimedinc-bcg-matrix.png?v=1772203791","url":"https:\/\/growthsharematrix.com\/products\/marimedinc-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}